治疗策略在Cenobamate治疗开始期间:德尔菲小组的建议
Bernhard J Steinhoff1,2, Elinor Ben-Menachem3, Pavel Klein4
1Department for Adults, Kork Epilepsy Center, Landstrasse 1, Kehl-Kork 77694, Germany.
Therapeutic advances in neurological disorders
|June 17, 2024
概括
这项研究提供了专家的共识,对对药物耐药性 (DRE) 进行管理的cenobamate. 它概述了定位和管理潜在药物相互作用的最佳实践,以改善控制和耐受性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床实践 临床实践
背景情况:
- 的治疗目的是使用抗发作药物 (ASM) 控制发作.
- 药物耐药性 (DRE) 发生时,尽管有两个充足的ASM试验,但发作仍然存在.
- 由于多疗法和药物相互作用,不良事件 (AE) 在DRE中很常见,影响了坚持和生活质量.
研究的目的:
- 建立基于共识的最佳实践,用于管理DRE患者的博酸定位.
- 为了解决塞诺巴酸盐的药理动力学和药理动力学相互作用.
- 为了最大限度地减少耐受性问题,并优化青酸盐剂量.
主要方法:
- 一个由专家病学家组成的国际德尔菲小组召开了会议.
- 一个经过修改的Delphi流程涉及一个开放式问卷和一个虚拟面对面的会议.
- 在定位期间和之后对管理巴治疗达成共识.
主要成果:
- 塞诺巴马特适用于大多数患有焦点发作的患者.
- 在Cenobamate定位期间,建议密切监测和医疗保健专业人员的接触,以100毫克的评估为准.
- 提供了关于同时服用药物的管理的具体指导,包括通道阻断剂 (SCB) 和与口服避孕药,抗凝剂和艾滋病毒药物的相互作用.
结论:
- 塞诺巴马特为DRE提供了一种有效的治疗选择.
- 在Cenobamate治疗期间,同时服用药物,特别是SCBs的积极管理至关重要.
- 个性化患者支持和监测对于成功治疗和耐受性至关重要.
更多相关视频
相关概念视频
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:26Drug Administration and Therapy Phases: Overview
447
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
447
01:22Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
01:24Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
01:30Electroconvulsive Therapy
31
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
31
01:26Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122